THAP9 and cancer: Our findings identified genetic mutations and indicated statistical correlations between the expression of THAP9 and THAP9-AS1 and clinical prognosis and several cancer-related pathways, which suggests that the gene pair can serve as a potential prognostic cancer biomarker.